A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD)
Clinical trial NCT02901431 · TERMINATED
Trial details
- NCT number
- NCT02901431
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2020-04-15
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.